[Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
D000328:Adult; D000368:Aged; D002752:Chlorthalidone / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007008:Hypokalemia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D010096:Oxprenolol / Q000627:therapeutic use*
D004338:Drug Combinations; D010096:Oxprenolol; D002752:Chlorthalidone
Vantaggi di un'associazione fissa oxprenololo-clortalidone, rispetto al clortalidone da solo, nel trattamento cronico dell'ipertensione arteriosa essenziale.